Literature DB >> 32383160

The show must go on.

T K Nguyen1, D Chua1, N B Shannon1, J C F Ng1, H K Tan1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32383160      PMCID: PMC7267535          DOI: 10.1002/bjs.11684

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


× No keyword cloud information.
Editor The COVID‐19 pandemic adds multiple layers of uncertainty to the already challenging practice of surgery. In a recent publication1, key disruptors to surgical workflow were identified and recommendations were given to mitigate these impacts. At the outbreak of COVID‐19, general surgery and related subspecialties at Singapore General Hospital were divided into two different groups: ‘hot’ and ‘cold’. The two groups further sub‐compartmentalized into small, consultant‐led subspecialty teams, functioning independently of one another to maintain social distancing. The ‘hot’ group, also known as enhanced acute care surgery (e‐ACS), is composed of five independent teams each of which goes on one 24‐h call every 5 days. The ‘cold’ group includes subspecialty teams that carry on with elective work. The benefit of dedicated COVID‐19 staff is unclear, and patients are not always tested for COVID‐19 in time2 so compartmentalization into small teams helps mitigate the risk of cross‐infection should there be virus transmission to a staff member. Given the rising demand to treat COVID‐positive patients, it seems counterintuitive to shift more manpower to acute care surgery; however we note a similar trend in Italy where it was required2. Although the number of acute cases was almost the same, we noticed a reduced length of stay from 4·8 days in February 2019 to 3·1 days in February 2020. This was a 35·4 per cent reduction in bed‐days per emergency surgical patient, which translates into an annual saving of 7911 bed‐days. As of 16 April 2020, there are more than 4400 confirmed cases of COVID‐19 in Singapore, which is over 750 cases per million people, the highest in the Asia Pacific region3. Although we willingly answer the call to ‘re‐direct [our] energies and works outside of [our] comfort zone’4, our unique and irreplaceable role in caring for acutely ill surgical patients must meet the demands and challenges of this pandemic.
  3 in total

1.  Surgical ethics during a pandemic: moving into the unknown?

Authors:  J Ives; R Huxtable
Journal:  Br J Surg       Date:  2020-04-20       Impact factor: 6.939

2.  COVID-19 pandemic: perspectives on an unfolding crisis.

Authors:  A Spinelli; G Pellino
Journal:  Br J Surg       Date:  2020-03-23       Impact factor: 6.939

Review 3.  Global guidance for surgical care during the COVID-19 pandemic.

Authors: 
Journal:  Br J Surg       Date:  2020-04-15       Impact factor: 6.939

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.